Dose-Dependent Efficacy of Tirzepatide vs Semaglutide f...

Insmed Incorporated announced the U.S. Food and Drug Administration (FDA) approval of BRINSUPRI™ (brensocatib 10 mg and 25 mg tablets), the first approved treatment for non-cystic fibrosis bronchiec...

Published: 20 Aug 2025

Written by Malavika Shylajan